Albumin is the most abundant protein in the circulation. Its main physiologic function is to maintain colloid osmotic pressure. Better understanding of albumin's other physiologic functions has ...

Zydus Lifesciences subsidiary has partnered with Zhuhai Beihai Biotech to market a cancer drug, Beizray (Albumin Solubilized ...

Sonnet's FHAB platform enables rapid development of targeted biologic drugs, with ongoing clinical ... validating the company's Fully Human Albumin Binding (FHAB®) technology.

The patent, Albumin Binding Domain Fusion Proteins No ... the company announced the issuance of US Patent No. 12,134,635, covering its new drug candidates, SON-1411 and SON-1400, which are ...

Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

Ahmedabad: Zydus Lifesciences Ltd., a global healthcare company has announced that its wholly owned subsidiary, Zydus ...

Aptamers are single-stranded DNA or RNA molecules with unique 3D structures that allow for specific binding to a wide variety of ions and molecules. Due to their unique properties, aptamers have been ...

Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (F H ...